By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

The U.S. private credit market has reached $2.1 trillion in assets under management (AUM) this year, surpassing the ...

Stream Finance pauses operations after a $93M loss and XUSD stablecoin drops 76%, highlighting transparency & risk issues in the DeFi sector.

Batman and Robin #27 hits stores this Wednesday! A mysterious new villain targets Gotham's rogues gallery. Who's hunting the ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...